XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
shares in Thousands, $ in Millions
Total
 Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (loss)
Beginning balance (in shares) at Mar. 31, 2022   280,051      
Beginning balance at Mar. 31, 2022 $ 7,625 $ 3 $ 0 $ 7,607 $ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 367     311 56
Stock-based compensation 125   125    
Issuance of common stock (in shares)   1,413      
Issuance of common stock (103)   (103)    
Common stock repurchases (in shares)   (2,512)      
Common stock repurchases (320)   (22) (298)  
Cash dividends declared ($0.19 per common share) (53)     (53)  
Ending balance (in shares) at Jun. 30, 2022   278,952      
Ending balance at Jun. 30, 2022 7,641 $ 3 0 7,567 71
Beginning balance (in shares) at Mar. 31, 2022   280,051      
Beginning balance at Mar. 31, 2022 7,625 $ 3 0 7,607 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income $ 732        
Common stock repurchases (in shares) (5,100)        
Common stock repurchases $ (645)        
Ending balance (in shares) at Sep. 30, 2022   277,024      
Ending balance at Sep. 30, 2022 7,798 $ 3 0 7,658 137
Beginning balance (in shares) at Jun. 30, 2022   278,952      
Beginning balance at Jun. 30, 2022 7,641 $ 3 0 7,567 71
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 365     299 66
Stock-based compensation 140   140    
Issuance of common stock (in shares)   641      
Issuance of common stock $ 30   30    
Common stock repurchases (in shares) (2,600) (2,569)      
Common stock repurchases $ (325)   (170) (155)  
Cash dividends declared ($0.19 per common share) (53)     (53)  
Ending balance (in shares) at Sep. 30, 2022   277,024      
Ending balance at Sep. 30, 2022 $ 7,798 $ 3 0 7,658 137
Beginning balance (in shares) at Mar. 31, 2023 270,000 272,914      
Beginning balance at Mar. 31, 2023 $ 7,293 [1] $ 3 0 7,357 (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 394     402 (8)
Stock-based compensation 130   130    
Issuance of common stock (in shares)   1,408      
Issuance of common stock (105)   (105)    
Common stock repurchases (in shares)   (2,574)      
Common stock repurchases and excise tax (326)   (25) (301)  
Cash dividends declared ($0.19 per common share) (52)     (52)  
Ending balance (in shares) at Jun. 30, 2023   271,748      
Ending balance at Jun. 30, 2023 $ 7,334 $ 3 0 7,406 (75)
Beginning balance (in shares) at Mar. 31, 2023 270,000 272,914      
Beginning balance at Mar. 31, 2023 $ 7,293 [1] $ 3 0 7,357 (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income $ 834        
Common stock repurchases (in shares) (5,200)        
Common stock repurchases $ (650)        
Ending balance (in shares) at Sep. 30, 2023 270,000 269,840      
Ending balance at Sep. 30, 2023 $ 7,575 $ 3 0 7,606 (34)
Beginning balance (in shares) at Jun. 30, 2023   271,748      
Beginning balance at Jun. 30, 2023 7,334 $ 3 0 7,406 (75)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 440     399 41
Stock-based compensation 155   155    
Issuance of common stock (in shares)   673      
Issuance of common stock $ 25   25    
Common stock repurchases (in shares) (2,600) (2,581)      
Common stock repurchases and excise tax $ (328)   (180) (148)  
Common stock repurchases (325)        
Cash dividends declared ($0.19 per common share) $ (51)     (51)  
Ending balance (in shares) at Sep. 30, 2023 270,000 269,840      
Ending balance at Sep. 30, 2023 $ 7,575 $ 3 $ 0 $ 7,606 $ (34)
[1] Derived from audited Consolidated Financial Statements.